A rare, inherited mutation confers an eightfold increased risk of prostate cancer, a recent study shows.

Vanderbilt researchers are investigating the potential benefits of prospective genetic testing for drug safety.

Vanderbilt University Medical Center doctors announced today they will begin screening patients who take commonly prescribed statin drugs for a rare genetic variation that can increase risks for side effects from these drugs such as muscle aches, kidney damage and even death.